Salute e Benessere
Duchenne Muscular Dystrophy Market on Track to Surpass US$ 7.4 Billion by 2034 at CAGR of 11.7% | Analysis by Transparency Market Research, Inc.
Owing to the surge in different demand drivers, the competitive landscape will navigate through different prospective chances, enabling the industry by 2034. The sector was valued at in 2023.
The progress of the industry is attributed to the rising prevalence of Duchenne muscular dystrophy. With the growing number of patients affected due to such a genetic disorder, the demand for treatment for such disorders is surging. This factor drives the industry size.
Statistics related to this rising number are indicative of the growing market for Duchenne muscular dystrophy. combined forecasted that about 6 of 100,000 people are likely to be affected with the disease.
With the proliferation of awareness campaigns, people have started to become more alert regarding the muscular disorder. This results in a rising number of patients approaching for medical help, which elevates prospects for the said sector.
Key players in the Duchenne muscular dystrophy industry are aiming to invest more in research and development projects. This will help such players to find new therapies and treatments to treat patients. Such developments will lead to the augmentation of the industry.
New technologies like exon skipping technology are emerging in the field, which benefits patients. Such a catalyst accelerates the growth of the ecosystem and generates more prospects for existing players.
Different tests, pertaining to the diseases, are gaining momentum in the sector, which is expected to predict the progression of the disease more accurately. As a result, more patients will likely benefit from accurate diagnosis.
The growing investments in the research and development sector are expected to fuel new inventions. Drug development and repurposing are expected to gain momentum in the forecasted era, attributing to the proliferation of the global Duchenne muscular dystrophy market.
Government initiatives to consolidate the healthcare infrastructure to cater to the diverse requirements of patients an indicative of a better future for the said sector. With the medical field being bolstered, better treatments in terms of efficiency and efficacy can be provided to patients.
The vast competitive landscape of Duchenne muscular dystrophy is explored by key players using product launches, partnerships, acquisitions, and many more.
, a global registered at Wilmington, Delaware , United States , provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
:
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
+1-518-618-1030
: 866-552-3453
https://www.transparencymarketresearch.com
sales@transparencymarketresearch.com
LinkedIn
Twitter Blog YouTube
View original content: https://www.prnewswire.co.uk/news-releases/duchenne-muscular-dystrophy-market-on-track-to-surpass-us-7-4-billion-by-2034-at-cagr-of-11-7--analysis-by-transparency-market-research-inc-302198214.html